Cost-effectiveness analysis of voriconazole versus amphotericin B in the treatment of invasive aspergillosis in Spain

被引：2
|
作者：
Grau, S
Mateu-de, AJ
Soto, J
Muñoz, M
Salas, E
机构：
[1] Univ Autonoma Barcelona, Hosp Mar, Dept Med, E-08003 Barcelona, Spain
[2] Pfizer SA, Madrid, Spain
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61912-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：750 / 751
页数：2
相关论文
共 50 条
  • [21] COST ANALYSIS OF VORICONAZOLE VERSUS LIPOSOMAL AMPHOTERICIN B FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS AMONG HEMATOLOGIC PATIENTS IN GERMANY
    Ostermann, H.
    Stephens, J.
    Gao, X.
    Weber, B.
    Charbonneau, C.
    VALUE IN HEALTH, 2012, 15 (07) : A389 - A389
  • [22] COST-EFFECTIVENESS ANALYSIS OF ISAVUCONAZOLE VERSUS LIPOSOMAL AMPHOTERICIN FOR THE TREATMENT OF INVASIVE MUCORMYCOSIS IN JORDAN
    Naser, A.
    Bilbisi, M.
    Mousa, R.
    VALUE IN HEALTH, 2023, 26 (12) : S145 - S145
  • [23] COST-EFFECTIVENESS ANALYSIS OF VORICONAZOLE, AMPHOTERICIN B AND CASPOFUNGIN FOR INVASIVE ASPERGILOSIS PATIENTS IN PUBLIC HOSPITALS IN DOMINICAN REPUBLIC
    Lutz, M. A.
    Blanco, C.
    Baudrit, M.
    Cuesta, G.
    VALUE IN HEALTH, 2012, 15 (04) : A55 - A56
  • [24] Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain
    Dominguez-Gil, Alfonso
    Martin, Isabel
    Garcia Vargas, Mercedes
    Del Castillo, Almudena
    Diaz, Silvia
    Sanchez, Cristina
    CLINICAL DRUG INVESTIGATION, 2007, 27 (03) : 197 - 205
  • [25] Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Spain
    Domínguez-Gil A.
    Martín I.
    Vargas M.G.
    Del Castillo A.
    Díaz S.
    Sánchez C.
    Clinical Drug Investigation, 2007, 27 (3) : 197 - 205
  • [26] ANALYSIS OF COST-EFFECTIVENESS OF ITRACONAZOLE IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN TURKISH SETTING
    Kanbur, B.
    Sarioz, F.
    Tatar, F.
    VALUE IN HEALTH, 2008, 11 (06) : A433 - A434
  • [27] COST-EFFECTIVENESS ANALYSIS OF ISAVUCONAZOLE FOR THE TREATMENT OF INVASIVE ASPERGILLOSIS IN THE CZECH REPUBLIC
    Hajickova, B.
    Mlcoch, T.
    Dolezal, T.
    Charbonneau, C.
    Sung, A.
    Vothova, P.
    Mazan, P.
    Billova, S.
    VALUE IN HEALTH, 2018, 21 : S232 - S232
  • [28] A cost-effectiveness analysis model for treatment of candidiasis and invasive aspergillosis in Mexico
    Quevedo, JFM
    Contreras, I
    Garcia-Contreras, F
    Nevarez, A
    Constantino-Casas, P
    Garduño, J
    VALUE IN HEALTH, 2005, 8 (03) : 308 - 308
  • [29] Invasive aspergillosis: Is treatment with "inexpensive" amphotericin B cost-saving if "expensive" voriconazole is only used on demand?
    Garbino, Jorge
    Schnetzler, Gabriel
    Roberts, Craig
    SWISS MEDICAL WEEKLY, 2006, 136 (39-40) : 624 - 630
  • [30] Cost-minimization analysis of voriconazole and caspofungin for the treatment of invasive candida and aspergillosis infections in Spain
    Domínguez-Gil, HA
    Herranz, MI
    Garcia, VM
    Rejas, J
    VALUE IN HEALTH, 2004, 7 (06) : 764 - 764
12345